Literature DB >> 31236598

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, I T Rubio, S Zackrisson, E Senkus.   

Abstract

Entities:  

Year:  2019        PMID： 31236598     DOI： 10.1093/annonc/mdz189

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  77 in total

1.  Impact of Recurrence Score on type and duration of chemotherapy in breast cancer.

Authors:  K Willemsma; W Yip; N LeVasseur; K Dobosz; C Illmann; S Baxter; C Lohrisch; C E Simmons
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

Review 2.  Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer.

Authors:  Marija Balic; Gabriel Rinnerthaler; Rupert Bartsch
Journal:  Breast Care (Basel)       Date:  2021-10-29       Impact factor: 2.860

3.  Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Authors:  Heikki Joensuu; Pirkko-Liisa Kellokumpu-Lehtinen; Riikka Huovinen; Arja Jukkola; Minna Tanner; Johan Ahlgren; Päivi Auvinen; Outi Lahdenperä; Kenneth Villman; Paul Nyandoto; Greger Nilsson; Paula Poikonen-Saksela; Vesa Kataja; Petri Bono; Jouni Junnila; Henrik Lindman
Journal:  J Clin Oncol       Date:  2022-01-12       Impact factor: 44.544

4.  Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.

Authors:  M Gabriela Kuba; Melissa P Murray; Kristen Coffey; Catarina Calle; Monica Morrow; Edi Brogi
Journal:  Mod Pathol       Date:  2021-04-06       Impact factor: 7.842

Review 5.  Integrating Adjuvant Radiation with Post-Neoadjuvant Therapies in Early Breast Cancer.

Authors:  Max S Mano; Leandro Jonata C Oliveira; Samir A Hanna
Journal:  Curr Oncol Rep       Date:  2021-03-26       Impact factor: 5.075

6.  Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.

Authors:  Patrick Neven; Giuseppe Floris; Laurence Slembrouck; Isabelle Vanden Bempt; Hans Wildiers; Ann Smeets; Anne-Sophie Van Rompuy; Chantal Van Ongeval; Lynn Jongen; Caroline Weltens; Kevin Punie; Griet Hoste; Els Van Nieuwenhuysen; Sileny Han; Ines Nevelsteen
Journal:  Mod Pathol       Date:  2021-02-08       Impact factor: 7.842

Review 7.  An Overview of PARP Inhibitors for the Treatment of Breast Cancer.

Authors:  Laura Cortesi; Hope S Rugo; Christian Jackisch
Journal:  Target Oncol       Date:  2021-03-12       Impact factor: 4.493

8.  Germline mutations in a clinic-based series of pregnancy associated breast cancer patients.

Authors:  Eleni Zografos; Anna-Maria Korakiti; Angeliki Andrikopoulou; Ioannis Rellias; Constantine Dimitrakakis; Spyridon Marinopoulos; Aris Giannos; Antonios Keramopoulos; Nikolaos Bredakis; Meletios-Athanasios Dimopoulos; Flora Zagouri
Journal:  BMC Cancer       Date:  2021-05-19       Impact factor: 4.430

9.  Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer.

Authors:  F Ayala de la Peña; B Ortiz-Muñoz; T Quintanar-Verdúguez; J D Santotoribio; S de la Cruz; J Trapé-Pujol; E Galve-Calvo; J M Augé-Fradera; J García-Gómez; Á González-Hernández
Journal:  Clin Transl Oncol       Date:  2021-02-07       Impact factor: 3.405

10.  Role of physiotherapy in supporting recovery from breast cancer treatment: a qualitative study embedded within the UK PROSPER trial.

Authors:  Sophie Rees; Bruno Mazuquin; Helen Richmond; Esther Williamson; Julie Bruce
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.